Answers are grounded in this paper and cite their sources.
Immunocompromised patients have an increased risk of dengue-related complications. However, definitive conclusions about the comparative severity of dengue across different immunocompromised patient groups are limited by a lack of robust data, highlighting the need for well-designed future studies.
No takes yet. Share an insight, caveat, or question.
Sohail et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: